Skip to content

Clinical trials

Active, not recruiting Glomerulonephritis, IGA trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Status: Active, not recruiting Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20201
20221
20234
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.2
Alexion Pharmaceuticals, Inc.1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Biocity Biopharmaceutics Co., Ltd.1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Hoffmann-La Roche1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
RemeGen Co., Ltd.1
Suzhou Sanegene Bio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA14
Renal Insufficiency, Chronic4
Glomerulonephritis3
Kidney Diseases2
Urologic Diseases2
Autoimmune Diseases1
Diabetic Nephropathies1
Glomerulonephritis, Membranous1
Immune System Diseases1
Proteinuria1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.